References
- RoehrBHalf a million Americans use methamphetamine every weekBMJ2005331476
- NaruseNMethamphetamine, cannabisNihon Rinsho2015731481148626394507
- KishimotoMUjikeHMotohashiYThe dysbindin gene (DTNBP1) is associated with methamphetamine psychosisBiol Psychiatry20086319119617555717
- MatsuzawaDHashimotoKMiyatakeRIdentification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosisAm J Psychiatry20071641105111417606663
- MahoneyJJ3rdKalechsteinADDe La GarzaR2ndNewtonTFPresence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participantsAm J Addict200817839818393050
- BatkiSLHarrisDSQuantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesiaAm J Addict20041346147015764424
- MoralesAMLeeBHellemannGO’NeillJLondonEDGray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamineDrug Alcohol Depend201212523023822445480
- LondonEDKohnoMMoralesAMBallardMEChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimagingBrain Res2015162817418525451127
- ChinKMChannickRNRubinLJIs methamphetamine use associated with idiopathic pulmonary arterial hypertension?Chest20061316571663
- IshigamiATokunagaIGotohdaTKuboSImmunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusersLeg Med (Tokyo)20035424812935649
- SatoMNumachiYHamamuraTRelapse of paranoid psychotic state in methamphetamine model of schizophreniaSchizophr Bull1992181151221553491
- SlayterEMUnderstanding and overcoming barriers to substance abuse treatment access for people with mental retardationJ Soc Work Disabil Rehabil20087638019042302
- VanDErNagelJKiewikMBuitellarJDeJongCStaff perspectives of substance use and misuse among adults with intellectual disabilities enrolled in Dutch disability servicesJ Policy Pract Intellect Disabil20118143149
- MatsonJLMahanSAntipsychotic drug side effects for persons with intellectual disabilityRes Dev Disabil2010311570157620580203
- PolednakAPPost-mortem neuropathology in a mentally retarded populationLancet1977149249365603
- MurasakiMNishikawaHIshibashiTDopamine-serotonin antagonist: receptor binding profile of a novel antipsychotic blonanserinJpn J Clin Psychopharmacol200811845854
- TenjinTMiyamotoSNinomiyaYProfile of blonanserin for the treatment of schizophreniaNeuropsychiatr Dis Treat2013958759423766647
- HidaHMouriAMoriKBlonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D3-5-HT2A and D1-NMDA receptors in the mPFCNeuropsychopharmacology20154060161325120077
- GarciaERobertMPerisFNakamuraHSatoNTerazawaYThe efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre studyCNS Drugs20092361562519552488
- DeeksEDKeatingGMBlonanserin: a review of its use in the management of schizophreniaCNS Drugs201024658420030420
- KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
- SawamuraJMorishitaSIshigookaJIs there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysisBMC Psychiatry20101010521134296
- MisraLKofoedLRisperidone treatment of methamphetamine psychosisAm J Psychiatry19971541170
- ShoptawSJKaoULingWWTreatment for amphetamine psychosisCochrane Database Syst Rev2008Cd00302618843639
- VerachaiVRuknganWChawanakrasaesinKTreatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapinePsychopharmacology (Berl)20142313099310824535654
- SulaimanAHGillJSSaidMAZainalNZHusseinHMGuanNCA randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosisInt J Psychiatry Clin Pract20131713113822486597
- LeelahanajTKongsakonRNetrakomPA 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosisJ Med Assoc Thai200588Suppl 3S43S52
- ParyRJDiscontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illnessAm J Ment Retard19951002072128527116
- StahlSMStahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Application3rd edCambridgeCambrige University Press2008
- NakajimaSGerretsenPTakeuchiHThe potential role of dopamine D3 receptor neurotransmission in cognitionEur Neuropsychopharmacol20132379981323791072